ET
Methodology breakdown computing — it will appear here on its own.
Eton Pharmaceuticals Inc (ETON) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.
Computing the full ratio and business-activity breakdown for ETON — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 52.60 | NEUTRAL |
| Stochastic %K (14) | 9.45 | BUY |
| CCI (20) | -117.46 | BUY |
| Williams %R (14) | -90.55 | BUY |
| MACD (12,26,9) | -1.17 | SELL |
| ROC (10) | -8.92 | SELL |
| Momentum (10) | -5.59 | SELL |
| EMA (10) | 58.95 | SELL |
| SMA (10) | 59.41 | SELL |
| EMA (20) | 57.68 | SELL |
| SMA (20) | 60.79 | SELL |
| EMA (30) | 55.37 | BUY |
| SMA (30) | 55.27 | BUY |
| EMA (50) | 50.87 | BUY |
| SMA (50) | 49.50 | BUY |
| EMA (100) | 42.78 | BUY |
| SMA (100) | 39.95 | BUY |
| EMA (200) | 32.98 | BUY |
| SMA (200) | 29.11 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Background via Yahoo Finance — informational, not part of the verdict.
🟢 STRONG BUY SETUP
Strong confluence across multiple layers — outperforming the market by 45.7%, RSI in healthy zone, Wall Street broadly bullish. High conviction entry. Use `!plan ETON [entry] [stop] [target]` to size the position properly.
Scores: 4 bullish / 1 bearish
Weak — low conviction, small size or skip
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 62 |
| ⏰ 4H | BEARISH | 40 |
| 🕐 1H | RANGING | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Peer movement computing — it will appear here on its own.
CLUSTER SELL 0 buys · 16 sells
Recent: Opaleye Management Inc. sold 2680000 sh @ $38.37 (2026-07-07); Opaleye Management Inc. sold 2700000 sh @ $38.00 (2026-07-06); Opaleye Management Inc. sold 2710000 sh @ $37.39 (2026-07-02)
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.